Literature DB >> 16176913

Synergy between sexual abuse and cervical cancer in causing sexual dysfunction.

Karin Bergmark1, Elisabeth Avall-Lundqvist, Paul W Dickman, Gunnar Steineck, Lars Henningsohn.   

Abstract

Experiencing a sexual abuse creates a life-long traumatic memory. The life-long effect of such abuse on sexuality, well-being, the risk of contracting cervical cancer, or problems after treatment for cervical cancer is not known. A population-based follow-up study in 1996-97 that used an anonymous postal questionnaire for data collection, 256 women with stage IB-IIA cervical cancer registered in 1991-92 in Sweden, and 350 women without cervical cancer frequency matched for age and region of residence, provided information. Among the women with a history of cervical cancer and the control women, 46 (18%) and 50 (15%), respectively, reported a history of sexual abuse. The follow-up was 1-70 years after the sexual abuse. The relative risk (with 95% confidence interval) of decreased well-being was 2.4 (1.1-5.2) among controls and 2.7 (1.1-6.4) among former cervical cancer patients. A history of both sexual abuse and cervical cancer gave a relative risk of 30.0 (7.0-129.0) for superficial dyspareunia. Sexual abuse increased the risk of sexual problems after treatment. The sexually abused cervical cancer patients were generally less willing than other patients to trade off possible maximal survival and forgo parts of the treatment. A history of sexual abuse and cervical cancer are both independent risk factors for sexual dysfunction and decreased well-being, and there may be a large synergy when both factors are combined. Diagnosis and treatment of cervical cancer may be improved by recognition of a sexual abuse history.

Entities:  

Mesh:

Year:  2005        PMID: 16176913     DOI: 10.1080/00926230591006476

Source DB:  PubMed          Journal:  J Sex Marital Ther        ISSN: 0092-623X


  7 in total

1.  Sexual health and wellbeing among female pelvic cancer survivors following individualized interventions in a nurse-led clinic.

Authors:  Linda Åkeflo; Gail Dunberger; Eva Elmerstig; Viktor Skokic; Gunnar Steineck; Karin Bergmark
Journal:  Support Care Cancer       Date:  2022-08-05       Impact factor: 3.359

2.  Barriers to cervical screening in women who have experienced sexual abuse: an exploratory study.

Authors:  Louise Cadman; Jo Waller; Lesley Ashdown-Barr; Anne Szarewski
Journal:  J Fam Plann Reprod Health Care       Date:  2012-10

Review 3.  Lived experiences and quality of life after gynaecological cancer-An integrative review.

Authors:  Ragnhild Johanne Tveit Sekse; Gail Dunberger; Mette Linnet Olesen; Maria Østerbye; Lene Seibaek
Journal:  J Clin Nurs       Date:  2019-01-11       Impact factor: 3.036

Review 4.  Body Image, Sexuality, and Sexual Functioning in Women With Gynecologic Cancer: An Integrative Review of the Literature and Implications for Research.

Authors:  Christina M Wilson; Deborah B McGuire; Beth L Rodgers; R K Elswick; Sarah M Temkin
Journal:  Cancer Nurs       Date:  2021 Sep-Oct 01       Impact factor: 2.592

5.  Sexuality post gynaecological cancer treatment: a qualitative study with South African women.

Authors:  Sorrel Pitcher; Nazia Fakie; Tracey Adams; Lynette Denny; Jennifer Moodley
Journal:  BMJ Open       Date:  2020-09-23       Impact factor: 2.692

6.  Sexual health and wellbeing after pelvic radiotherapy among women with and without a reported history of sexual abuse: important issues in cancer survivorship care.

Authors:  Linda Åkeflo; Eva Elmerstig; Gail Dunberger; Viktor Skokic; Amanda Arnell; Karin Bergmark
Journal:  Support Care Cancer       Date:  2021-05-18       Impact factor: 3.603

7.  Cohort profile: an observational longitudinal data collection of health aspects in a cohort of female cancer survivors with a history of pelvic radiotherapy-a population-based cohort in the western region of Sweden.

Authors:  Linda Åkeflo; Gail Dunberger; Eva Elmerstig; Viktor Skokic; Gunnar Steineck; Karin Bergmark
Journal:  BMJ Open       Date:  2021-07-21       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.